The Case for the Use of Patient and Caregiver Perception of Change Assessments in Rare Disease Clinical Trials: A Methodologic Overview Marielle G. ContesseJames E. ValentineMindy G. Leffler Commentary Open access 16 March 2019 Pages: 997 - 1010
Reporting Clinical Trial Results of Phytomedicines in Acute Rhinosinusitis: Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi: 10.1007/s12325-018-0736-7 Claus BachertMayank ThakurDimitri Abramov-Sommariva Letter 26 March 2019 Pages: 1011 - 1013
Response Letter Addressing Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi:10.1007/s12325-018-0736-7 Stefan GottschlichKristina RöschmannHenning Candler Letter 26 March 2019 Pages: 1014 - 1017
Differentiating Basal Insulin Preparations: Understanding How They Work Explains Why They Are Different Alice Y. Y. ChengDhiren K. PatelKathleen Wyne Review Open access 30 March 2019 Pages: 1018 - 1030
Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist Dhiren PatelCurtis TriplittJennifer Trujillo Review Open access 21 March 2019 Pages: 1031 - 1051
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease Sven FrancqueLuisa Vonghia Review Open access 19 March 2019 Pages: 1052 - 1074
Bloating and Abdominal Distension: Clinical Approach and Management Amir MariFadi Abu BackerRam Dickman Review Open access 16 March 2019 Pages: 1075 - 1084
Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials Germain HonvoOlivier BruyèreJean-Yves Reginster Review Open access 16 March 2019 Pages: 1085 - 1099
Economic Burden of Illness Among Commercially Insured Patients with Systemic Sclerosis with Interstitial Lung Disease in the USA: A Claims Data Analysis Zhou ZhouYanni FanAryeh Fischer Original Research Open access 30 March 2019 Pages: 1100 - 1113
Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China Haijing GuanYanan ShengLuwen Shi Original Research 21 March 2019 Pages: 1114 - 1125
The Effectiveness, Safety, and Tolerability of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Retrospective Study Ismail HantaAykut CilliCan Sevinc Original Research 21 March 2019 Pages: 1126 - 1131
A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus Xia HuLei ZhangWeiguo Gao Original Research Open access 21 March 2019 Pages: 1132 - 1142
The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding Nazmiye Koyuncu Original Research 21 March 2019 Pages: 1143 - 1149
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study Olof BorgåRoger HenrikssonNiklas Loman Original Research Open access 16 March 2019 Pages: 1150 - 1163
Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1 Omar DabbousBenit MaruDouglas M. Sproule Original Research Open access 16 March 2019 Pages: 1164 - 1176
Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group Massimiliano FilostoStefano Cotti PiccinelliAntonio Toscano Original Research 16 March 2019 Pages: 1177 - 1189
A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA Pierre JohansenBarnaby HuntRichard F. Pollock Original Research Open access 14 March 2019 Pages: 1190 - 1199
Correction to: A Relative Cost of Control Analysis of Once-Weekly Semaglutide Versus Exenatide Extended-Release and Dulaglutide for Bringing Patients to HbA1c and Weight Loss Treatment Targets in the USA Pierre JohansenBarnaby HuntRichard F. Pollock Correction Open access 12 April 2019 Pages: 1200 - 1200
Switching “Real-World” Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control Nikolaos TentolourisSøren T. KnudsenBernd Schultes Original Research Open access 16 March 2019 Pages: 1201 - 1210
Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study Qiong YangZhiyong WuKefeng Lei Original Research 16 March 2019 Pages: 1211 - 1220
Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease Eniko BarcziLivia StarobinskiVeronika Müller Brief Report 14 March 2019 Pages: 1221 - 1232
Correction to: Safety and Efficacy of Ripasudil in Japanese Patients with Glaucoma or Ocular Hypertension: 3-month Interim Analysis of ROCK-J, a Post-Marketing Surveillance Study Hidenobu TaniharaTakahiko KakudaRyoji Gunji Correction 13 March 2019 Pages: 1233 - 1234